Imatinib for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours

Technology appraisal guidance
Reference number: TA209
Published: 24 November 2010

History

Background information

TA209 Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib: review decision - October 2013 information
TA209 Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib: Appendix A - decision paper presented to the Institute's Guidance Executive (PDF 109 KB)

Published:

21 October 2013
TA209 Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib: review proposal information
TA209 Imatinib for gastrointestinal stromal tumours: Appendix A - provisional matrix of stakeholders (PDF 102 KB)

Published:

27 August 2013
TA209 Imatinib for gastrointestinal stromal tumours: Appendix B - proposal paper presented to the Institute's Guidance Executive (PDF 467 KB)

Published:

27 August 2013
Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib: press release information
2010/166 Insufficient new evidence on increased doses of imatinib for treating GISTs (PDF 72 KB)

Published:

06 December 2013

Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): Equality impact assessment

Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): Equality impact assessment (PDF 17 KB)

Published:

21 February 2011

Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): rejected appeal

Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): rejected appeal information
Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): appeal announcement information
Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): appeal received (PDF 84 KB)

Published:

24 November 2010
Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): initial scrutiny (PDF 69 KB)

Published:

24 November 2010
Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): response to scrutiny (PDF 6.8 KB)

Published:

24 November 2010
Gastrointestinal stromal tumours (unresectable/metastatic) - imatinib (review): final scrutiny letter (PDF 18 KB)

Published:

24 November 2010

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): final appraisal determination

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): final appraisal determination information
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): final appraisal determination (PDF 211 KB)

Published:

16 September 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): response to consultee, commentator and public comments on the ACD and comments from website consultation (PDF 152 KB)

Published:

16 September 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the ACD
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee comments
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Novartis (manufacturer) response (PDF 36 KB)

Published:

16 September 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Royal College of Nursing response (PDF 23 KB)

Published:

16 September 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Royal College of Pathologists response (PDF 9.1 KB)

Published:

16 September 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Royal College of Physicians (on behalf of many) response to ACD (PDF 55 KB)

Published:

16 September 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Royal College of Physicians (on behalf of many) response to evaluation report (PDF 31 KB)

Published:

16 September 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): commentator comments
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Department of Health response (PDF 36 KB)

Published:

16 September 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): NHS Quality Improvement Scotland response (PDF 9.4 KB)

Published:

16 September 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Pfizer response (PDF 52 KB)

Published:

16 September 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Welsh Assembly Government response (PDF 13 KB)

Published:

16 September 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): responses from the Assessment Group (PDF 107 KB)

Published:

16 September 2010

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): appraisal consultation

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): appraisal consultation
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): appraisal consultation document information
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review) - appraisal consultation: evaluation report
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review) - appraisal consultation: overview (PDF 261 KB)

Published:

29 June 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review) - appraisal consultation: assessment report (PDF 592 KB)

Published:

29 June 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review) - appraisal consultation: erratum to the assessment report (PDF 52 KB)

Published:

29 June 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review) - appraisal consultation: consultee and commentator comments on the assessment report
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Department of Health (PDF 32 KB)

Published:

29 June 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - NHS Quality Improvement Scotland (PDF 24 KB)

Published:

29 June 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Novartis (PDF 99 KB)

Published:

29 June 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Pfizer (PDF 69 KB)

Published:

29 June 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Royal College of Nursing (PDF 44 KB)

Published:

29 June 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Royal college of Physicians (PDF 62 KB)

Published:

29 June 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Royal College of Pathologists (PDF 33 KB)

Published:

29 June 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): consultee and commentator comments on the assessment report - Welsh Assembly Government (PDF 38 KB)

Published:

29 June 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review) - appraisal consultation: non-manufacturer submissions
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): non-manufacturer submissions - GIST Support UK (PDF 20 KB)

Published:

29 June 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): non-manufacturer submissions - Royal College of Physicians (PDF 23 KB)

Published:

29 June 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): manufacturer submissions - Novartis (executive summary) (PDF 17 KB)

Published:

29 June 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review) - appraisal consultation: expert written personal statements
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): expert written personal statements - Cook (PDF 14 KB)

Published:

29 June 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): expert written personal statements - Judson (PDF 14 KB)

Published:

29 June 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): expert written personal statements - Reid (PDF 52 KB)

Published:

29 June 2010
Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): expert written personal statements - Robinson (PDF 40 KB)

Published:

29 June 2010

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): assessment report

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): assessment report (PDF 1.44 MB)

Published:

28 April 2010

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): final protocol

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): final protocol (PDF 172 KB)

Published:

17 November 2009

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): final scope

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): final scope (PDF 27 KB)

Published:

21 August 2009

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): final matrix of consultee and commentators

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): final matrix of consultee and commentators (PDF 33 KB)

Published:

21 August 2009

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Institute's response to consultee and commentator comments on the draft scope

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): Institute's response to consultee and commentator comments on the draft scope (PDF 81 KB)

Published:

21 August 2009

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): draft scope

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): draft scope (PDF 32 KB)

Published:

02 July 2009

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): provisional matrix of consultee and commentators

Gastro-intestinal stromal tumours (unresectable/metastatic) - imatinib (review): provisional matrix of consultee and commentators (PDF 33 KB)

Published:

02 July 2009